A California jury on Friday awarded $40 million to two women who claimed that Johnson & Johnson’s baby powder caused them to develop ovarian cancer, The Guardian reports.

The Los Angeles Superior Court ordered the company to pay $18 million to Monica Kent and $22 million to Deborah Schultz and her husband, concluding that Johnson & Johnson had known for many years about the dangers of its talc-based products but failed to warn consumers.

Johnson & Johnson Vice President for Litigation Erik Haas said the company intends to “immediately appeal this verdict and expects to prevail, as is typically the case with such anomalous decisions.”

According to court documents, Monica Kent was diagnosed with ovarian cancer in 2014, and Deborah Schultz in 2018. Both women live in California and said they used Johnson & Johnson baby powder after bathing for about 40 years. During the trial, they testified that their treatment involved major surgeries and dozens of rounds of chemotherapy.

In his closing argument, plaintiffs’ attorney Andy Birchfield told the jury that Johnson & Johnson had been aware of the carcinogenic risks of its products since the 1960s. He said the company had “deliberately concealed and buried the truth about the danger.”

Johnson & Johnson attorney Allison Brown, in turn, argued that the only people who told Kent and Schultz that their cancer was caused by talc were their lawyers. She emphasized that the alleged link has not been confirmed by any major U.S. health authority and that there are no studies proving talc can migrate from the surface of the body to the reproductive organs.

According to court filings, Johnson & Johnson is facing more than 67,000 lawsuits from people who claim they developed cancer after using the company’s baby powder and other talc products. Johnson & Johnson maintains that its products are safe, asbestos-free, and do not cause cancer. In 2020, the company stopped selling talc-based baby powder in the United States, replacing it with a cornstarch-based product.